United States Biotechnology & Medical Research

Uniqure NV (QURE)

Track

Track

Uniqure NV experienced significant insider trading activity over the past ninety days, totaling sixteen transactions. Executives, including the CEO and Chief Medical Officer, executed sales worth approximately 10.3 million dollars. These divestments occurred following a recent earnings report that missed expectations, while the stock price remains relatively stable despite broader market fluctuations.
Ticker: QURE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Uniqure NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
493.44
Quantity 84,162 -28.9%
Value US$295,283
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
169.88
Quantity 27,407 -34.9%
Value US$2,393,095
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
492.83
Quantity 34,123 +33.1%
Value US$4,998,663
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
45.15
Quantity 21,082
Value US$951,932
1.8
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.40
Quantity 20,000 -11.9%
Value US$928,000
1.8
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.46
Quantity 10,000 -5.6%
Value US$464,600
2.3
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
46.43
Quantity 17,060 -39.6%
Value US$792,096
2.3
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
46.49
Quantity 4,107 -13.6%
Value US$190,934
1.8
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Proposed sale
Price
46.42
Quantity 30,000
Value US$1,392,643
2.3
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
46.44
Quantity 21,167
Value US$983,033
1.8
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Sale
Price
46.86
Quantity 1,434 -0.8%
Value US$67,197
1.8
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Proposed sale
Price
46.86
Quantity 1,434
Value US$67,197
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.02
Quantity 28,716 -5.2%
Value US$1,436,374
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
50.02
Quantity 28,716
Value US$1,436,305
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 6,696 -1.3%
Value US$334,800
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 6,696
Value US$334,800
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 37,015 -6.6%
Value US$1,850,750
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 37,015 -6.6%
Value US$1,850,750
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 4,656 -0.8%
Value US$232,800
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 4,656 -0.8%
Value US$232,800
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
46.38
Quantity 41,671
Value US$1,932,516
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
42.60
Quantity 1,690 -3.8%
Value US$71,994
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
42.60
Quantity 1,690 -3.8%
Value US$71,994
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
43.66
Quantity 4,700 -9.5%
Value US$205,202
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
43.66
Quantity 4,700 -9.5%
Value US$205,202
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
47.08
Quantity 5,295 -9.6%
Value US$249,289
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
47.08
Quantity 5,295 -9.6%
Value US$249,289
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
48.65
Quantity 11,585 -2.0%
Value US$563,610
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
48.65
Quantity 11,585 -2.0%
Value US$563,610
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.01
Quantity 33,334 -5.5%
Value US$1,500,363
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.01
Quantity 33,334 -5.5%
Value US$1,500,363
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.43
Quantity 56,929 -8.6%
Value US$2,472,426
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.43
Quantity 56,929 -8.6%
Value US$2,472,426
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.02
Quantity 32,581 -4.7%
Value US$1,466,797
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.02
Quantity 32,581 -4.7%
Value US$1,466,797
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.70
Quantity 6,023 -0.9%
Value US$263,205
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.70
Quantity 6,023 -0.9%
Value US$263,205
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
42.61
Quantity 23,977 -3.3%
Value US$1,021,660
2.3
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
42.57
Quantity 5,295 -16.9%
Value US$225,408
2.3
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
42.57
Quantity 5,295 -16.9%
Value US$225,408
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
43.00
Quantity 164,429
Value US$7,070,447
2.3
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
42.57
Quantity 5,295
Value US$225,393
2.2
Balachandran Madhavan Director Non-Executive Director
Transaction date
Proposed sale
Price
45.05
Quantity 11,685
Value US$526,463
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
27.85
Quantity 10,000 -18.8%
Value US$278,500
1.8
Potts Jeannette Chief Legal Officer Officer
Transaction date
Sale
Price
27.67
Quantity 5,237 -3.8%
Value US$144,908
1.8
Potts Jeannette Officer; CHIEF LEGAL OFFICER Officer
Transaction date
Proposed sale
Price
27.67
Quantity 5,237
Value US$144,886
2.5
Meek David D. Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.8%
Value US$53,931
2.8
Gut Robert Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 2,726 -7.8%
Value US$73,766
O'Keefe Kylie Chief Customer & Strat Officer Officer
Transaction date
Sale
Price
27.06
Quantity 15,936 -12.8%
Value US$431,228
2.3
Springhorn Jeremy P. Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.4%
Value US$53,931
2.2
POST LEONARD E Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -5.3%
Value US$53,931
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.4%
Value US$53,931
2.3
Kaye Jack Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -7.1%
Value US$53,931
2.2
Balachandran Madhavan Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.4%
Value US$53,931
2.0
Jacques Rachelle Suzanne Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.0
Jacques Rachelle Suzanne Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.3
Springhorn Jeremy P. Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.3
Springhorn Jeremy P. Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.2
POST LEONARD E Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.2
POST LEONARD E Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
O'Keefe Kylie Officer; Chief Customer and Strategy Officer Officer
Transaction date
Proposed sale
Price
27.06
Quantity 15,936
Value US$431,290
O'Keefe Kylie Officer; Chief Customer and Strategy Officer Officer
Transaction date
Proposed sale
Price
27.06
Quantity 15,936
Value US$431,290
2.5
Meek David D. Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.2
Balachandran Madhavan Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 11,993
Value US$324,578
2.3
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.8
Gut Robert Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 2,726
Value US$73,776
2.8
Gut Robert Non-Executive Director
Transaction date
Planned sale
Price
26.05
Quantity 1,780 -6.1%
Value US$46,369
2.8
Gut Robert Non-Executive Director
Transaction date
Planned sale
Price
26.03
Quantity 3,127 -9.7%
Value US$81,396
2.8
Gut Robert Non-Executive Director
Transaction date
Planned sale
Price
26.07
Quantity 2,645 -7.6%
Value US$68,955
2.8
Gut Robert Director Non-Executive Director
Transaction date
Proposed sale
Price
26.05
Quantity 7,552
Value US$196,725
2.3
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
30.01
Quantity 2,645 -11.5%
Value US$79,376
2.3
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
30.01
Quantity 2,645 -11.5%
Value US$79,376
2.3
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
30.01
Quantity 2,645
Value US$79,384
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-02 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
84,162 -28.9%
493.44
US$295,283 		84,162 -28.9% 493.44 US$295,283
2026-07-07 2026-07-02 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
27,407 -34.9%
169.88
US$2,393,095 		27,407 -34.9% 169.88 US$2,393,095
2026-07-07 2026-07-02 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
34,123 +33.1%
492.83
US$4,998,663 		34,123 +33.1% 492.83 US$4,998,663
2026-07-02 2026-07-02 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
21,082
45.15
US$951,932 		21,082 45.15 US$951,932
2026-07-02 2026-06-30 PlS Planned sale
1.8
Abi-Saab Walid

Chief Medical Officer

Officer
20,000 -11.9%
46.40
US$928,000 		20,000 -11.9% 46.40 US$928,000
2026-07-02 2026-06-30 PlS Planned sale
1.8
Abi-Saab Walid

Chief Medical Officer

Officer
10,000 -5.6%
46.46
US$464,600 		10,000 -5.6% 46.46 US$464,600
2026-07-02 2026-06-30 PlS Planned sale
2.3
Kaye Jack
Non-Executive Director
17,060 -39.6%
46.43
US$792,096 		17,060 -39.6% 46.43 US$792,096
2026-07-02 2026-06-30 PlS Planned sale
2.3
Kaye Jack
Non-Executive Director
4,107 -13.6%
46.49
US$190,934 		4,107 -13.6% 46.49 US$190,934
2026-06-30 2026-06-30 PrS Proposed sale
1.8
Abi-Saab Walid

Chief Medical Officer

Officer
30,000
46.42
US$1,392,643 		30,000 46.42 US$1,392,643
2026-06-30 2026-06-30 PrS Proposed sale
2.3
Kaye Jack

Director

Non-Executive Director
21,167
46.44
US$983,033 		21,167 46.44 US$983,033
2026-06-30 2026-06-26 S Sale
1.8
Abi-Saab Walid

Chief Medical Officer

Officer
1,434 -0.8%
46.86
US$67,197 		1,434 -0.8% 46.86 US$67,197
2026-06-26 2026-06-26 PrS Proposed sale
1.8
Abi-Saab Walid

Chief Medical Officer

Officer
1,434
46.86
US$67,197 		1,434 46.86 US$67,197
2026-06-26 2026-06-25 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
28,716 -5.2%
50.02
US$1,436,374 		28,716 -5.2% 50.02 US$1,436,374
2026-06-25 2026-06-25 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
28,716
50.02
US$1,436,305 		28,716 50.02 US$1,436,305
2026-06-26 2026-06-24 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
6,696 -1.3%
50.00
US$334,800 		6,696 -1.3% 50.00 US$334,800
2026-06-24 2026-06-24 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
6,696
50.00
US$334,800 		6,696 50.00 US$334,800
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
37,015 -6.6%
50.00
US$1,850,750 		37,015 -6.6% 50.00 US$1,850,750
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
37,015 -6.6%
50.00
US$1,850,750 		37,015 -6.6% 50.00 US$1,850,750
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
4,656 -0.8%
50.00
US$232,800 		4,656 -0.8% 50.00 US$232,800
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
4,656 -0.8%
50.00
US$232,800 		4,656 -0.8% 50.00 US$232,800
2026-06-18 2026-06-18 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
41,671
46.38
US$1,932,516 		41,671 46.38 US$1,932,516
2026-06-22 2026-06-17 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
1,690 -3.8%
42.60
US$71,994 		1,690 -3.8% 42.60 US$71,994
2026-06-22 2026-06-17 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
1,690 -3.8%
42.60
US$71,994 		1,690 -3.8% 42.60 US$71,994
2026-06-22 2026-06-17 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
4,700 -9.5%
43.66
US$205,202 		4,700 -9.5% 43.66 US$205,202
2026-06-22 2026-06-17 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
4,700 -9.5%
43.66
US$205,202 		4,700 -9.5% 43.66 US$205,202
2026-06-22 2026-06-17 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
5,295 -9.6%
47.08
US$249,289 		5,295 -9.6% 47.08 US$249,289
2026-06-22 2026-06-17 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
5,295 -9.6%
47.08
US$249,289 		5,295 -9.6% 47.08 US$249,289
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
11,585 -2.0%
48.65
US$563,610 		11,585 -2.0% 48.65 US$563,610
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
11,585 -2.0%
48.65
US$563,610 		11,585 -2.0% 48.65 US$563,610
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
33,334 -5.5%
45.01
US$1,500,363 		33,334 -5.5% 45.01 US$1,500,363
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
33,334 -5.5%
45.01
US$1,500,363 		33,334 -5.5% 45.01 US$1,500,363
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
56,929 -8.6%
43.43
US$2,472,426 		56,929 -8.6% 43.43 US$2,472,426
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
56,929 -8.6%
43.43
US$2,472,426 		56,929 -8.6% 43.43 US$2,472,426
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
32,581 -4.7%
45.02
US$1,466,797 		32,581 -4.7% 45.02 US$1,466,797
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
32,581 -4.7%
45.02
US$1,466,797 		32,581 -4.7% 45.02 US$1,466,797
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
6,023 -0.9%
43.70
US$263,205 		6,023 -0.9% 43.70 US$263,205
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
6,023 -0.9%
43.70
US$263,205 		6,023 -0.9% 43.70 US$263,205
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
23,977 -3.3%
42.61
US$1,021,660 		23,977 -3.3% 42.61 US$1,021,660
2026-06-22 2026-06-17 PlS Planned sale
2.3
Kaye Jack
Non-Executive Director
5,295 -16.9%
42.57
US$225,408 		5,295 -16.9% 42.57 US$225,408
2026-06-22 2026-06-17 PlS Planned sale
2.3
Kaye Jack
Non-Executive Director
5,295 -16.9%
42.57
US$225,408 		5,295 -16.9% 42.57 US$225,408
2026-06-17 2026-06-17 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
164,429
43.00
US$7,070,447 		164,429 43.00 US$7,070,447
2026-06-17 2026-06-17 PrS Proposed sale
2.3
Kaye Jack

Director

Non-Executive Director
5,295
42.57
US$225,393 		5,295 42.57 US$225,393
2026-06-17 2026-06-17 PrS Proposed sale
2.2
Balachandran Madhavan

Director

Non-Executive Director
11,685
45.05
US$526,463 		11,685 45.05 US$526,463
2026-06-17 2026-06-15 PlS Planned sale
2.2
Balachandran Madhavan
Non-Executive Director
10,000 -18.8%
27.85
US$278,500 		10,000 -18.8% 27.85 US$278,500
2026-06-17 2026-06-15 S Sale
1.8
Potts Jeannette

Chief Legal Officer

Officer
5,237 -3.8%
27.67
US$144,908 		5,237 -3.8% 27.67 US$144,908
2026-06-15 2026-06-15 PrS Proposed sale
1.8
Potts Jeannette

Officer; CHIEF LEGAL OFFICER

Officer
5,237
27.67
US$144,886 		5,237 27.67 US$144,886
2026-06-12 2026-06-11 S Sale
2.5
Meek David D.
Non-Executive Director
1,993 -4.8%
27.06
US$53,931 		1,993 -4.8% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.8
Gut Robert
Non-Executive Director
2,726 -7.8%
27.06
US$73,766 		2,726 -7.8% 27.06 US$73,766
2026-06-12 2026-06-11 S Sale
O'Keefe Kylie

Chief Customer & Strat Officer

Officer
15,936 -12.8%
27.06
US$431,228 		15,936 -12.8% 27.06 US$431,228
2026-06-12 2026-06-11 S Sale
2.3
Springhorn Jeremy P.
Non-Executive Director
1,993 -4.4%
27.06
US$53,931 		1,993 -4.4% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.2
POST LEONARD E
Non-Executive Director
1,993 -5.3%
27.06
US$53,931 		1,993 -5.3% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.0
Jacques Rachelle Suzanne
Non-Executive Director
1,993 -5.6%
27.06
US$53,931 		1,993 -5.6% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.2
Balachandran Madhavan
Non-Executive Director
1,993 -4.4%
27.06
US$53,931 		1,993 -4.4% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.3
Kaye Jack
Non-Executive Director
1,993 -7.1%
27.06
US$53,931 		1,993 -7.1% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.0
Jacques Rachelle Suzanne
Non-Executive Director
1,993 -5.6%
27.06
US$53,931 		1,993 -5.6% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.2
Balachandran Madhavan
Non-Executive Director
1,993 -4.4%
27.06
US$53,931 		1,993 -4.4% 27.06 US$53,931
2026-06-11 2026-06-11 PrS Proposed sale
2.0
Jacques Rachelle Suzanne

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.0
Jacques Rachelle Suzanne

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.3
Springhorn Jeremy P.

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.3
Springhorn Jeremy P.

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.2
POST LEONARD E

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.2
POST LEONARD E

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
O'Keefe Kylie

Officer; Chief Customer and Strategy Officer

Officer
15,936
27.06
US$431,290 		15,936 27.06 US$431,290
2026-06-11 2026-06-11 PrS Proposed sale
O'Keefe Kylie

Officer; Chief Customer and Strategy Officer

Officer
15,936
27.06
US$431,290 		15,936 27.06 US$431,290
2026-06-11 2026-06-11 PrS Proposed sale
2.5
Meek David D.

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.2
Balachandran Madhavan

Director

Non-Executive Director
11,993
27.06
US$324,578 		11,993 27.06 US$324,578
2026-06-11 2026-06-11 PrS Proposed sale
2.3
Kaye Jack

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.8
Gut Robert

Director

Non-Executive Director
2,726
27.06
US$73,776 		2,726 27.06 US$73,776
2026-06-12 2026-06-10 PlS Planned sale
2.8
Gut Robert
Non-Executive Director
1,780 -6.1%
26.05
US$46,369 		1,780 -6.1% 26.05 US$46,369
2026-06-12 2026-06-10 PlS Planned sale
2.8
Gut Robert
Non-Executive Director
3,127 -9.7%
26.03
US$81,396 		3,127 -9.7% 26.03 US$81,396
2026-06-12 2026-06-10 PlS Planned sale
2.8
Gut Robert
Non-Executive Director
2,645 -7.6%
26.07
US$68,955 		2,645 -7.6% 26.07 US$68,955
2026-06-10 2026-06-10 PrS Proposed sale
2.8
Gut Robert

Director

Non-Executive Director
7,552
26.05
US$196,725 		7,552 26.05 US$196,725
2026-06-05 2026-06-03 PlS Planned sale
2.3
Kaye Jack
Non-Executive Director
2,645 -11.5%
30.01
US$79,376 		2,645 -11.5% 30.01 US$79,376
2026-06-05 2026-06-03 PlS Planned sale
2.3
Kaye Jack
Non-Executive Director
2,645 -11.5%
30.01
US$79,376 		2,645 -11.5% 30.01 US$79,376
2026-06-03 2026-06-03 PrS Proposed sale
2.3
Kaye Jack

Director

Non-Executive Director
2,645
30.01
US$79,384 		2,645 30.01 US$79,384
Explore more

More insider trading research around Uniqure NV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America